Straumann Holding AG (SAUHY)
13.25
-0.30
(-2.25%)
USD |
OTCM |
May 17, 16:00
Straumann Total Assets (Quarterly): 3.955B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.955B |
| June 30, 2023 | 3.809B |
| June 30, 2023 | 3.809B |
| December 31, 2022 | 3.639B |
| June 30, 2022 | 3.339B |
| June 30, 2022 | 3.339B |
| December 31, 2021 | 3.247B |
| June 30, 2021 | 3.059B |
| June 30, 2021 | 3.059B |
| December 31, 2020 | 2.917B |
| June 30, 2020 | 2.296B |
| June 30, 2020 | 2.296B |
| December 31, 2019 | 2.467B |
| June 30, 2019 | 2.280B |
| June 30, 2019 | 2.280B |
| December 31, 2018 | 1.894B |
| June 30, 2018 | 1.718B |
| June 30, 2018 | 1.718B |
| December 31, 2017 | 1.742B |
| June 30, 2017 | 1.240B |
| June 30, 2017 | 1.240B |
| Date | Value |
|---|---|
| December 31, 2016 | 1.071B |
| June 30, 2016 | 1.211B |
| June 30, 2016 | 1.211B |
| December 31, 2015 | 1.059B |
| June 30, 2015 | 1.115B |
| June 30, 2015 | 1.115B |
| December 31, 2014 | 1.174B |
| June 30, 2014 | 1.181B |
| June 30, 2014 | 1.181B |
| December 31, 2013 | 1.149B |
| June 30, 2013 | 1.014B |
| June 30, 2013 | 1.014B |
| December 31, 2012 | 850.99M |
| June 30, 2012 | 843.92M |
| June 30, 2012 | 843.92M |
| December 31, 2011 | 866.89M |
| June 30, 2011 | 947.45M |
| December 31, 2010 | 913.49M |
| June 30, 2010 | 766.76M |
| December 31, 2009 | 775.37M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.280B
Minimum
Jun 2019
3.955B
Maximum
Dec 2023
3.053B
Average
3.059B
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| AC Immune SA | 185.40M |
| CRISPR Therapeutics AG | 2.439B |
| Addex Therapeutics Ltd | 5.526M |
| NLS Pharmaceutics Ltd | 1.847M |
| Molecular Partners AG | 236.15M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.766B |
| Shareholders Equity (Quarterly) | 2.186B |
| Debt to Equity Ratio | 0.1089 |
| Current Ratio | 1.947 |
| Net Debt Paydown Yield | -0.31% |